PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. (PAXH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 05-31. Amounts in USD.

Revenue Quarterly

0 100 200 300 Q4 '21: 286 Q1 '22: 41 Q2 '22: 230 Q3 '22: 70 Q4 '22: 27 Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 0 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q3 '26: 0 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Gross Profit Quarterly

0 Q1 '23: 0 Q1 '24: 0 Q1 '23 Q1 '24

Operating Income Quarterly

-900K -600K -300K 0 300K 600K 900K Q4 '21: -39.7K Q1 '22: -41.5K Q2 '22: -43.7K Q3 '22: -46.8K Q4 '22: -48.7K Q1 '23: -37.3K Q2 '23: -45.1K Q3 '23: -36.5K Q4 '23: -37.3K Q1 '24: -40.9K Q2 '24: -45.1K Q3 '24: -8.8K Q4 '24: -4.6K Q1 '25: -4.6K Q2 '25: -13.7K Q3 '25: -13.5K Q4 '25: -120.4K Q1 '26: -875.2K Q2 '26: -112.1K Q3 '26: -94.7K Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Net Income Quarterly

-900K -600K -300K 0 300K 600K 900K Q4 '21: -39.7K Q1 '22: -41.5K Q2 '22: -43.7K Q3 '22: -46.8K Q4 '22: -48.7K Q1 '23: -37.3K Q2 '23: -45.1K Q3 '23: -36.5K Q4 '23: -37.3K Q1 '24: -40.9K Q2 '24: -45.1K Q3 '24: -8.8K Q4 '24: -4.6K Q1 '25: -4.6K Q2 '25: -13.7K Q3 '25: -13.5K Q4 '25: -50.3K Q1 '26: -875.1K Q2 '26: -111.8K Q3 '26: -94.3K Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Cost of Revenue Quarterly

0 Q1 '23: 0 Q1 '24: 0 Q1 '23 Q1 '24

Operating Cash Flow Quarterly

-90K -60K -30K 0 30K 60K 90K Q4 '21: -6.9K Q1 '22: -9.1K Q2 '22: -20K Q3 '22: -16K Q4 '22: -18.9K Q1 '23: -13.3K Q2 '23: -10.7K Q3 '23: -7.9K Q4 '23: -5.7K Q1 '24: -13.6K Q2 '24: -2.8K Q3 '24: -674 Q4 '24: -13.8K Q1 '25: -2.4K Q2 '25: -16.2K Q3 '25: -5K Q4 '25: -17.9K Q1 '26: -74.8K Q2 '26: -38.9K Q3 '26: 5.1K Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Free Cash Flow Quarterly

-150K -100K -50K 0 50K 100K 150K Q3 '25: -5K Q3 '26: -132K Q3 '25 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '14: 16.7M Q1 '15: 17.7M Q2 '15: 17.7M Q3 '15: 17.7M Q1 '16: 17.7M Q2 '16: 17.7M Q3 '16: 17.7M Q3 '17: 18.4M Q1 '23: 19.8M Q2 '23: 19.8M Q3 '23: 19.8M Q1 '24: 19.8M Q2 '24: 19.8M Q3 '24: 19.8M Q1 '25: 19.8M Q2 '25: 19.8M Q3 '25: 19.8M Q1 '26: 19.8M Q2 '26: 43.5M Q3 '26: 44.2M Q1 '15 Q1 '16 Q3 '17 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.04 -0.03 -0.01 0.00 0.01 0.03 0.04 Q3 '20: -0.00 Q4 '20: -0.01 Q1 '21: -0.01 Q2 '21: -0.01 Q3 '21: -0.01 Q4 '21: -0.01 Q1 '22: -0.01 Q2 '22: -0.01 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: -0.01 Q1 '25: -0.01 Q2 '25: -0.01 Q3 '25: -0.01 Q4 '25: -0.00 Q1 '26: -0.04 Q2 '26: -0.04 Q3 '26: -0.04 Q4 '20 Q3 '21 Q2 '22 Q2 '24 Q1 '25 Q4 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.